0001709056-17-000001.txt : 20170621 0001709056-17-000001.hdr.sgml : 20170621 20170621130427 ACCESSION NUMBER: 0001709056-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170621 DATE AS OF CHANGE: 20170621 EFFECTIVENESS DATE: 20170621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Falcon Therapeutics, Inc. CENTRAL INDEX KEY: 0001709056 IRS NUMBER: 474454466 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-289154 FILM NUMBER: 17922507 BUSINESS ADDRESS: STREET 1: 60110 DAVIE CITY: CHAPEL HILL STATE: NC ZIP: 27517 BUSINESS PHONE: 919-360-5321 MAIL ADDRESS: STREET 1: 60110 DAVIE CITY: CHAPEL HILL STATE: NC ZIP: 27517 D 1 primary_doc.xml X0707 D LIVE 0001709056 Falcon Therapeutics, Inc. 60110 DAVIE CHAPEL HILL NC NORTH CAROLINA 27517 919-360-5321 NORTH CAROLINA None None Corporation true 2015 Karen J. Giroux c/o Falcon Therapeutics, Inc. 60110 Davie Chapel Hill NC NORTH CAROLINA 27517 Executive Officer Director Anna M. Seal c/o Falcon Therapeutics, Inc. 60110 Davie Chapel Hill NC NORTH CAROLINA 27517 Executive Officer Director Shawn D. Hingtgen c/o Falcon Therapeutics, Inc. 60110 Davie Chapel Hill NC NORTH CAROLINA 27517 Director Matthew G. Ewend c/o Falcon Therapeutics, Inc. 60110 Davie Chapel Hill NC NORTH CAROLINA 27517 Director Biotechnology Decline to Disclose 06b false 2017-06-06 false true false 0 700000 700000 0 false 2 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director, or promoter will receive any payments from the proceeds of this offering. false Falcon Therapeutics, Inc. /s/ Karen J. Giroux Karen J. Giroux President and Chief Executive Officer 2017-06-19